JP2024536768A - 操作された抗微生物ペプチドおよびその使用 - Google Patents

操作された抗微生物ペプチドおよびその使用 Download PDF

Info

Publication number
JP2024536768A
JP2024536768A JP2024516799A JP2024516799A JP2024536768A JP 2024536768 A JP2024536768 A JP 2024536768A JP 2024516799 A JP2024516799 A JP 2024516799A JP 2024516799 A JP2024516799 A JP 2024516799A JP 2024536768 A JP2024536768 A JP 2024536768A
Authority
JP
Japan
Prior art keywords
arg
val
trp
seq
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024516799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536768A5 (enExample
Inventor
ディー． ステックベック，ジョナサン
エヌ． ピコーン，ブラッド
エックス． ドビンズ，デスピナ
Original Assignee
ぺプチロジックス，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ぺプチロジックス，インク． filed Critical ぺプチロジックス，インク．
Publication of JP2024536768A publication Critical patent/JP2024536768A/ja
Publication of JP2024536768A5 publication Critical patent/JP2024536768A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2024516799A 2021-09-17 2022-09-16 操作された抗微生物ペプチドおよびその使用 Pending JP2024536768A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163245774P 2021-09-17 2021-09-17
US63/245,774 2021-09-17
PCT/US2022/076560 WO2023044423A1 (en) 2021-09-17 2022-09-16 Engineered antimicrobial peptides and usage thereof

Publications (2)

Publication Number Publication Date
JP2024536768A true JP2024536768A (ja) 2024-10-08
JP2024536768A5 JP2024536768A5 (enExample) 2026-01-21

Family

ID=85603623

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024516799A Pending JP2024536768A (ja) 2021-09-17 2022-09-16 操作された抗微生物ペプチドおよびその使用

Country Status (6)

Country Link
US (1) US20240252586A1 (enExample)
EP (1) EP4401752A4 (enExample)
JP (1) JP2024536768A (enExample)
AU (1) AU2022346034A1 (enExample)
CA (1) CA3231958A1 (enExample)
WO (1) WO2023044423A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230106943A1 (en) * 2021-09-17 2023-04-06 Peptilogics, Inc. Engineered antimicrobial peptides and usage thereof
CN115305226B (zh) * 2022-09-22 2023-06-16 郑州轻工业大学 一株降解烟碱并产氢的抗辐射不动杆菌zj-22及其应用
CN119639630B (zh) * 2025-02-12 2025-05-06 云南农业大学 一株皮特不动杆菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3576755A4 (en) * 2017-02-02 2020-12-02 McMaster University BICARBONATE AS A POTENTIALIZER OF ANTIMICROBIAL AGENTS
WO2018160997A1 (en) * 2017-03-03 2018-09-07 Peptilogics, Inc. Engineered antimicrobial amphiphilic peptides and methods of use
US20240317809A1 (en) * 2021-05-12 2024-09-26 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Engineered Antimicrobial Peptides and Usage Thereof

Also Published As

Publication number Publication date
US20240252586A1 (en) 2024-08-01
EP4401752A1 (en) 2024-07-24
WO2023044423A1 (en) 2023-03-23
AU2022346034A1 (en) 2024-04-04
EP4401752A4 (en) 2025-07-16
CA3231958A1 (en) 2023-03-23

Similar Documents

Publication Publication Date Title
JP2024536768A (ja) 操作された抗微生物ペプチドおよびその使用
US10464975B2 (en) Stabilized anti-microbial peptides
Blanchette et al. Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections
US20140357592A1 (en) Composition
US20250277002A1 (en) Engineered antimicrobial amphiphilic peptides and methods of use
CN1816330A (zh) 抗菌组合物,方法和系统
EP3655105A2 (en) Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
US20220249599A1 (en) Treatment of implants with engineered antimicrobial amphiphilic peptides
JP5812465B2 (ja) 抗アカントアメーバ用組成物、アカントアメーバ角膜炎の予防及び治療剤並びにコンタクトレンズケア溶液
EP3370794B1 (en) Antimicrobial solutions with enhanced stability
US20220117924A1 (en) Compositions of Glycerol and /or Non-Toxic Amino Acids for Inhibiting and Destroying Biofilm, including Related Methods
EP2306972A1 (en) Acetic acid and a buffer
US20250320266A1 (en) Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections
US20240115654A1 (en) Intravenous administration of engineered antimicrobial amphiphilic peptides
US20230106943A1 (en) Engineered antimicrobial peptides and usage thereof
JP6269946B2 (ja) 細菌の増殖抑制
WO2022241117A2 (en) Engineered antimicrobial peptides and usage thereof
CN118265536A (zh) 工程化抗菌肽及其用途
WO2025094120A1 (en) Cationic peptides with broad spectrum activity
EP2337850A2 (en) Anti-protozoa compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240325

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250912

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250912

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260109